Experiment 520087
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | SLEDGE JR,GW: ROBERT,N: SPARANO,JA: COBELIGH,M: GOLDSTEIN,LJ: NEUBERG,D: ROWINSKY,E: BAUGHMAN,C: MC CASKILL-STEVENS,W:. (1994). PACLITAXEL (TAXOL)/DOXORUBICIN COMBINATIONS IN ADVANCED BREAST CANCER: THE EASTERN COOPERATIVE ONCOLOGY GROUP EXPERIENCE.. 21(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE I STUDY OF EFFICACY OF COTHERAPY WITH DOXORUBICIN CMPD GIVEN OVER 24 HOURS AFTER 50 MG/M2 IV PUSH OF LATTER AND GRANULOCYTE-CSF. FIVE OF 12 PATIENTS SHOWED RESPONSE. MUCOSITIS WAS A SIDE-EFFECT MORE FREQUENCY IF DOXORUBICIN FOLLOWED CMPD IN DOSING. |
| Dose amount | 150.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | MAXIMUM TOLERATED DOSE |